Sofinnova Investments as of March 31, 2024
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera (NTRA) | 7.9 | $142M | 1.6M | 91.46 | |
Vera Therapeutics Cl A (VERA) | 6.7 | $121M | 2.8M | 43.12 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 6.3 | $114M | 754k | 151.17 | |
Aerovate Therapeutics (AVTE) | 6.2 | $111M | 3.8M | 29.57 | |
Merck & Co (MRK) | 4.8 | $86M | 651k | 131.95 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.5 | $81M | 850k | 94.89 | |
Novo-Nordisk A S Adr (NVO) | 4.4 | $79M | 612k | 128.40 | |
Incyte Corporation (INCY) | 4.2 | $76M | 1.3M | 56.97 | |
Argenx SE Sponsored Adr (ARGX) | 3.3 | $59M | 149k | 393.72 | |
Intuitive Surgical (ISRG) | 3.1 | $56M | 141k | 399.09 | |
Dyne Therapeutics (DYN) | 3.1 | $55M | 1.9M | 28.39 | |
Inhibrx | 2.5 | $46M | 1.3M | 34.96 | |
Elanco Animal Health (ELAN) | 2.3 | $42M | 2.6M | 16.28 | |
IDEXX Laboratories (IDXX) | 2.3 | $41M | 75k | 539.93 | |
AstraZeneca Sponsored Adr (AZN) | 2.3 | $40M | 597k | 67.75 | |
Syndax Pharmaceuticals (SNDX) | 2.1 | $38M | 1.6M | 23.80 | |
Insulet Corporation (PODD) | 2.1 | $38M | 220k | 171.40 | |
Y Mabs Therapeutics (YMAB) | 2.0 | $36M | 2.2M | 16.26 | |
Ideaya Biosciences (IDYA) | 1.9 | $34M | 782k | 43.88 | |
Celldex Therapeutics (CLDX) | 1.9 | $34M | 802k | 41.97 | |
Inozyme Pharma (INZY) | 1.8 | $33M | 4.3M | 7.66 | |
Align Technology (ALGN) | 1.7 | $31M | 96k | 327.92 | |
Arrivent Biopharma (AVBP) | 1.7 | $30M | 1.7M | 17.86 | |
Tg Therapeutics (TGTX) | 1.7 | $30M | 2.0M | 15.21 | |
Sarepta Therapeutics (SRPT) | 1.6 | $30M | 228k | 129.46 | |
Marinus Pharmaceuticals (MRNS) | 1.6 | $29M | 3.3M | 9.04 | |
Boston Scientific Corporation (BSX) | 1.4 | $24M | 354k | 68.49 | |
Immatics NV SHS (IMTX) | 1.3 | $23M | 2.2M | 10.51 | |
Silk Road Medical Inc Common (SILK) | 1.2 | $22M | 1.2M | 18.32 | |
Cogent Biosciences (COGT) | 0.9 | $16M | 2.4M | 6.72 | |
EXACT Sciences Corporation (EXAS) | 0.9 | $16M | 230k | 69.06 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $15M | 103k | 149.45 | |
Immunome (IMNM) | 0.8 | $15M | 594k | 24.68 | |
Pharvaris N V (PHVS) | 0.8 | $14M | 585k | 23.11 | |
Savara (SVRA) | 0.7 | $12M | 2.3M | 4.98 | |
Shockwave Med | 0.6 | $11M | 35k | 325.63 | |
Kura Oncology (KURA) | 0.6 | $11M | 502k | 21.33 | |
Roivant Sciences SHS (ROIV) | 0.6 | $11M | 1.0M | 10.54 | |
Axonics Modulation Technolog (AXNX) | 0.6 | $10M | 149k | 68.97 | |
Pepgen (PEPG) | 0.4 | $7.4M | 504k | 14.70 | |
Cabaletta Bio (CABA) | 0.4 | $7.3M | 430k | 17.06 | |
Establishment Labs Holdings Ord (ESTA) | 0.4 | $7.2M | 141k | 50.90 | |
Achieve Life Sciences (ACHV) | 0.4 | $6.9M | 1.5M | 4.54 | |
Soleno Therapeutics (SLNO) | 0.4 | $6.5M | 151k | 42.80 | |
4d Molecular Therapeutics In (FDMT) | 0.4 | $6.3M | 198k | 31.86 | |
Nextcure (NXTC) | 0.3 | $6.0M | 2.7M | 2.23 | |
Avantor (AVTR) | 0.3 | $5.9M | 232k | 25.57 | |
Madrigal Pharmaceuticals (MDGL) | 0.3 | $5.1M | 19k | 267.04 | |
Bolt Biotherapeutics (BOLT) | 0.2 | $3.9M | 2.8M | 1.40 | |
Fusion Pharmaceuticals | 0.2 | $3.4M | 157k | 21.32 | |
Masimo Corporation (MASI) | 0.2 | $2.9M | 20k | 146.85 | |
Teleflex Incorporated (TFX) | 0.2 | $2.7M | 12k | 226.17 | |
Insmed Com Par $.01 Call Option (INSM) | 0.2 | $2.7M | 100k | 27.13 | |
Cooper Cos (COO) | 0.1 | $2.2M | 21k | 101.46 | |
Inspire Med Sys (INSP) | 0.1 | $1.7M | 8.1k | 214.79 | |
Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.7M | 607k | 2.84 | |
LivaNova SHS (LIVN) | 0.1 | $1.1M | 21k | 55.94 | |
Nucana Sponsored Adr | 0.0 | $884k | 3.4M | 0.26 | |
Baxter International (BAX) | 0.0 | $855k | 20k | 42.74 | |
Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.0 | $853k | 316k | 2.70 | |
Pds Biotechnology Ord (PDSB) | 0.0 | $565k | 143k | 3.96 | |
IsoRay (CATX) | 0.0 | $512k | 430k | 1.19 | |
Inari Medical Ord (NARI) | 0.0 | $490k | 10k | 47.98 | |
Disc Medicine (IRON) | 0.0 | $384k | 6.2k | 62.26 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $374k | 8.7k | 42.86 | |
Nucana Common Shares | 0.0 | $340k | 1.3M | 0.26 | |
Kyverna Therapeutics (KYTX) | 0.0 | $248k | 10k | 24.84 | |
Ikena Oncology (IKNA) | 0.0 | $164k | 116k | 1.42 | |
Mirum Pharmaceuticals (MIRM) | 0.0 | $76k | 3.0k | 25.12 |